Search
S-(Methylmercury)-L-Cysteine
go.drugbank.com/drugs/DB02750ExperimentalSynonyms: S-(Methylmercury)-L-CysteineS-(3-Iodobenzyl)glutathione
go.drugbank.com/drugs/DB04341ExperimentalSynonyms: S-(3-Iodobenzyl)glutathioneS-(4-BROMOBENZYL)CYSTEINE
go.drugbank.com/drugs/DB08370ExperimentalSynonyms: S-(4-BROMOBENZYL)CYSTEINE(S)-2-Tetrahydrofuroic acid
go.drugbank.com/drugs/DB03051ExperimentalSynonyms: (S)-2-Tetrahydrofuroic acid, (S)-(-)-2-Tetrahydrofuroic acidAstraZeneca COVID-19 Vaccine
go.drugbank.com/drugs/DB15656ApprovedInvestigationaladenovirus capable of producing the spike (S) protein of SARS-CoV-2, allowing for the formation of endogenous antibodies against these proteins and, consequently, against SARS-CoV-2. … Upon review, the European Medicines Agency (EMA) determined that the vaccine was not associated with a higher overall risk of blood clots, but that it may be associated with very rare instances of blood
Synonyms: ChAdOx-1-S[recombinant], ChAdOx1-S [recombinant]Metamfetamine
go.drugbank.com/drugs/DB01577ApprovedIllicitInvestigationalWithdrawnMetamfetamine (methamphetamine) is a psychostimulant and sympathomimetic drug, and a member of the amphetamine group of sympathomimetic amines. … It is a scheduled drug in most countries due to its high potential for addiction and abuse.
Categories: Cytochrome P-450 Substrates, Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substratesSynonyms: (+)-(S)-N-α-dimethylphenethylamine, (S)-N,α-dimethylbenzeneethanamineDuloxetine
go.drugbank.com/drugs/DB00476ApprovedInvestigationalDuloxetine is a dual serotonin and norepinephrine reuptake inhibitor.[label] It was originally discovered in 1993 and developed by Eli Lilly and Company as LY248686. … [A178741] Duloxetine first received approval from the FDA in August, 2004 as Cymbalta for the treatment of Major Depressive Disorder.
Categories: P-glycoprotein inhibitors, Cytochrome P-450 SubstratesSynonyms: (S)-duloxetine, (3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine